| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |